Guanylate cyclase C (GUCY2C) as a preventative and therapeutic target in colorectal cancers (CRCs) arising through divergent genomic pathways.

Authors

• Scott Waldman

Publication/Presentation Date

1-2019

Volume

37

Issue

4

Published In/Presented At

DOI: 10.1200/JCO.2019.37.4_suppl.595

Disciplines

Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods

Department(s)

Administration and Leadership

Document Type

Article